Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Apple
AAPL
|
$168M |
| 2 |
PACCAR
PCAR
|
$165M |
| 3 |
Exxon Mobil
XOM
|
$120M |
| 4 |
GE HealthCare
GEHC
|
$103M |
| 5 |
Visa
V
|
$96.1M |
Top Sells
| 1 |
Walmart
WMT
|
$331M |
| 2 |
JPMorgan Chase
JPM
|
$199M |
| 3 |
Thermo Fisher Scientific
TMO
|
$98.9M |
| 4 |
ConocoPhillips
COP
|
$80.4M |
| 5 |
NVIDIA
NVDA
|
$66.9M |
Sector Composition
| 1 | Technology | 16.86% |
| 2 | Financials | 16.13% |
| 3 | Industrials | 13.08% |
| 4 | Healthcare | 11.06% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBIO
3326
Crescent Biopharma, Inc. Common Stock
CBIO
$189M
| $84.1K | ﹤0.01% |
66,785
-7,493
| -10% | -$9.44K |
|
|
RVLP
3327
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $82.9K | ﹤0.01% |
72,664
-23,487
| -24% | -$26.8K |
|
3328
Absci
ABSI
$351M
| $82K | ﹤0.01% |
46,840
| – | – |
|
3329
Flux Power
FLUX
$25.3M
| $81.2K | ﹤0.01% |
16,718
| – | – |
|
3330
Sonida Senior Living
SNDA
$478M
| $81.1K | ﹤0.01% |
11,941
-8,218
| -41% | -$55.8K |
|
|
WPRT
3331
Westport Fuel Systems
WPRT
$47.9M
| $81.1K | ﹤0.01% |
85,265
-956
| -1% | -$909 |
|
|
SYRS
3332
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $80.7K | ﹤0.01% |
30,226
| – | – |
|
|
NEWP
3333
New Pacific Metals
NEWP
$330M
| $80.2K | ﹤0.01% |
29,802
-2,860
| -9% | -$7.69K |
|
3334
Outdoor Holding Company Common Stock
POWW
$167M
| $79.9K | ﹤0.01% |
40,546
-76,285
| -65% | -$150K |
|
3335
Immunoprecise Antibodies
IPA
$90.5M
| $79.4K | ﹤0.01% |
28,652
+991
| +4% | +$2.75K |
|
3336
fuboTV
FUBO
$1.29B
| $79.3K | ﹤0.01% |
65,983
-76
| -0.1% | -$91 |
|
|
LGO
3337
Largo
LGO
$94.9M
| $79.3K | ﹤0.01% |
15,301
| – | – |
|
3338
Altisource Portfolio Solutions
ASPS
$124M
| $78.5K | ﹤0.01% |
17,062
-3,157
| -16% | -$14.5K |
|
|
CELL
3339
DELISTED
PhenomeX Inc. Common Stock
CELL
| $78.4K | ﹤0.01% |
67,611
-8,143
| -11% | -$9.45K |
|
3340
Virgin Galactic
SPCE
$178M
| $77.4K | ﹤0.01% |
19,102
+7,183
| +60% | +$29.1K |
|
3341
Immunome
IMNM
$808M
| $77K | ﹤0.01% |
+15,433
| New | +$77K |
|
3342
Lightpath Technologies
LPTH
$211M
| $76.9K | ﹤0.01% |
54,543
-34,320
| -39% | -$48.4K |
|
3343
WidePoint Corp
WYY
$48.2M
| $76.5K | ﹤0.01% |
42,264
-1,219
| -3% | -$2.21K |
|
3344
Precigen
PGEN
$1.42B
| $76.3K | ﹤0.01% |
72,160
-34,940
| -33% | -$37K |
|
3345
Sera Prognostics
SERA
$126M
| $76.3K | ﹤0.01% |
+19,921
| New | +$76.3K |
|
3346
CEL-SCI Corp
CVM
$83.3M
| $75.1K | ﹤0.01% |
32,389
-5,811
| -15% | -$13.5K |
|
3347
Cartesian Therapeutics
RNAC
$255M
| $74.9K | ﹤0.01% |
53,850
| – | – |
|
3348
Nautilus Biotechnolgy
NAUT
$84.2M
| $74.4K | ﹤0.01% |
+26,870
| New | +$74.4K |
|
3349
Sono-Tek
SOTK
$52.7M
| $74.4K | ﹤0.01% |
14,534
-2,191
| -13% | -$11.2K |
|
3350
Oxbridge Re Holdings
OXBR
$14.8M
| $73.2K | ﹤0.01% |
41,369
-13,384
| -24% | -$23.7K |
|